INVESTORS & MEDIA
News Release
Regeneron Announces Upcoming Investor Conference Presentations
Bank of America Merrill Lynch 2019 Healthcare Conference at8:00 a.m. Pacific Time (11:00 a.m. Eastern Time ) onWednesday, May 15, 2019 Barclays 2019 Biopharmaceuticals CEO/CFO Conference Call Series at11:00 a.m. Eastern Time onFriday, May 17, 2019 - UBS 2019 Global Healthcare Conference at
10:00 a.m. Eastern Time onMonday, May 20, 2019
The sessions may be accessed from the "Investors & Media" page of Regeneron's website at http://investor.regeneron.com/events-and-presentations. Replays of the conference call and webcasts will be archived on the Company's website and will be available for 30 days.
About
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Contact Information:
Investor Relations
914.847.3482
mark.hudson@regeneron.com
Corporate Communications
914.847.3422
hala.mirza@regeneron.com
View original content:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300839896.html
SOURCE